Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saurabh Rajguru

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Chinese Clinical Oncology|April 6, 2015
Mantle cell lymphoma-management in evolutionSaurabh Rajguru, Brad S Kahl
Journal of the National Comprehensive Cancer Network : JNCCN|September 6, 2014
Emerging therapy for the treatment of mantle cell lymphomaSaurabh Rajguru, Brad S Kahl
Clinical Advances in Hematology & Oncology : H&O|October 31, 2014
Yttrium 90-ibritumomab tiuxetan plus rituximab maintenance as initial therapy for patients with high-tumor-burden follicular lymphoma: a Wisconsin Oncology Network studySaurabh Rajguru, Thorhildur Kristinsdottir, Jens Eickhoff, et al.
Leukemia & Lymphoma|June 10, 2024
Maintenance low-dose fixed duration lenalidomide and rituximab following bendamustine and rituximab induction in previously untreated chronic lymphocytic leukemia and small lymphocytic lymphomaJulie E Chang, Tuo Wang, KyungMann Kim, et al.
The Oncologist|June 5, 2016
A Phase II Trial of a Histone Deacetylase Inhibitor Panobinostat in Patients With Low-Grade Neuroendocrine TumorsNing Jin, Sam J Lubner, Daniel L Mulkerin, et al.
Clinical Breast Cancer|January 17, 2025
A Phase II Trial of Onapristone and Fulvestrant for Patients With ER+ and HER2- Metastatic Breast CancerSailaja Kamaraju, Amy M Fowler, Sergey Tarima, et al.
British Journal of Haematology|July 30, 2016
Sole rearrangement but not amplification of MYC is associated with a poor prognosis in patients with diffuse large B cell lymphoma and B cell lymphoma unclassifiableDaniel J Landsburg, Marissa K Falkiewicz, Adam M Petrich, et al.
Blood|August 28, 2014
Impact of induction regimen and stem cell transplantation on outcomes in double-hit lymphoma: a multicenter retrospective analysisAdam M Petrich, Mitul Gandhi, Borko Jovanovic, et al.
Blood Advances|October 24, 2023
Outcomes of patients with blastoid and pleomorphic variant mantle cell lymphomaJames N Gerson, Elizabeth Handorf, Diego Villa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 8, 2019
Survival Outcomes of Younger Patients With Mantle Cell Lymphoma Treated in the Rituximab EraJames N Gerson, Elizabeth Handorf, Diego Villa, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Chinese Clinical Oncology|April 6, 2015
Mantle cell lymphoma-management in evolutionSaurabh Rajguru, Brad S Kahl
Journal of the National Comprehensive Cancer Network : JNCCN|September 6, 2014
Emerging therapy for the treatment of mantle cell lymphomaSaurabh Rajguru, Brad S Kahl
Clinical Advances in Hematology & Oncology : H&O|October 31, 2014
Yttrium 90-ibritumomab tiuxetan plus rituximab maintenance as initial therapy for patients with high-tumor-burden follicular lymphoma: a Wisconsin Oncology Network studySaurabh Rajguru, Thorhildur Kristinsdottir, Jens Eickhoff, et al.
Leukemia & Lymphoma|June 10, 2024
Maintenance low-dose fixed duration lenalidomide and rituximab following bendamustine and rituximab induction in previously untreated chronic lymphocytic leukemia and small lymphocytic lymphomaJulie E Chang, Tuo Wang, KyungMann Kim, et al.
The Oncologist|June 5, 2016
A Phase II Trial of a Histone Deacetylase Inhibitor Panobinostat in Patients With Low-Grade Neuroendocrine TumorsNing Jin, Sam J Lubner, Daniel L Mulkerin, et al.
Clinical Breast Cancer|January 17, 2025
A Phase II Trial of Onapristone and Fulvestrant for Patients With ER+ and HER2- Metastatic Breast CancerSailaja Kamaraju, Amy M Fowler, Sergey Tarima, et al.
British Journal of Haematology|July 30, 2016
Sole rearrangement but not amplification of MYC is associated with a poor prognosis in patients with diffuse large B cell lymphoma and B cell lymphoma unclassifiableDaniel J Landsburg, Marissa K Falkiewicz, Adam M Petrich, et al.
Blood|August 28, 2014
Impact of induction regimen and stem cell transplantation on outcomes in double-hit lymphoma: a multicenter retrospective analysisAdam M Petrich, Mitul Gandhi, Borko Jovanovic, et al.
Blood Advances|October 24, 2023
Outcomes of patients with blastoid and pleomorphic variant mantle cell lymphomaJames N Gerson, Elizabeth Handorf, Diego Villa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 8, 2019
Survival Outcomes of Younger Patients With Mantle Cell Lymphoma Treated in the Rituximab EraJames N Gerson, Elizabeth Handorf, Diego Villa, et al.
Pageof 1